High coffee intake is associated with lower grade nonalcoholic fatty liver disease: the role of peripheral antioxidant activity
- PMID: 22481454
High coffee intake is associated with lower grade nonalcoholic fatty liver disease: the role of peripheral antioxidant activity
Abstract
Background & aims: Some phytochemicals present in coffee have a potential antioxidant role which seems to protect the human body against cardiovascular diseases, liver disease and malignancies. Nonalcoholic fatty liver disease is a common disease with limited therapeutic options. This study investigated the antioxidant effect of coffee by measuring antioxidant enzymes and lipid peroxidation markers in patients with nonalcoholic fatty liver disease.
Material and methods: We performed a case-control study at the University Hospital, Mexico City. Anthropometric, metabolic, dietary and biochemical variables of all patients were determined and compared. The presence of nonalcoholic fatty liver disease was established by ultrasonography. All patients completed a dietary questionnaire in order to determine their of coffee consumption. Catalase, superoxide dismutase and thiobarbituric acid reactive substances were measured in all of the patients.
Results: Seventy-three subjects with and 57 without nonalcoholic fatty liver disease were included. Patients with nonalcoholic fatty liver disease had significantly higher body mass index, blood glucose, homeostasis model of assessment-insulin resistance and insulin values in comparison to patients without nonalcoholic fatty liver disease. On the one hand, there was a significant difference in coffee intake between the groups (p < 0.05, for all comparisons). There was no significant difference between groups in catalase (0.39 ± 0.74 vs. 0.28 ± 0.69 nM/min/mL), superoxide dismutase (5.4 ± 3.45 vs. 4.7 ± 2.1 U/mL) or thiobarbituric acid-reactive substances (4.05 ± 1.87 vs. 3.94 ± 1.59 µM/mL).
Conclusions: A high intake of coffee has a protective effect against nonalcoholic fatty liver disease however there was no significant difference in the antioxidant variables analyzed.
Similar articles
-
Coffee and Liver Disease.J Clin Exp Hepatol. 2016 Mar;6(1):40-6. doi: 10.1016/j.jceh.2016.02.003. Epub 2016 Feb 27. J Clin Exp Hepatol. 2016. PMID: 27194895 Free PMC article. Review.
-
Blood redox status is associated with the likelihood of nonalcoholic fatty liver disease irrespectively of diet's total antioxidant capacity.Nutr Res. 2015 Jan;35(1):41-8. doi: 10.1016/j.nutres.2014.11.004. Epub 2014 Dec 2. Nutr Res. 2015. PMID: 25530013
-
Coffee and non-alcoholic fatty liver disease: brewing evidence for hepatoprotection?J Gastroenterol Hepatol. 2014 Mar;29(3):435-41. doi: 10.1111/jgh.12422. J Gastroenterol Hepatol. 2014. PMID: 24199670 Review.
-
Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD).J Clin Gastroenterol. 2006 Nov-Dec;40(10):930-5. doi: 10.1097/01.mcg.0000212608.59090.08. J Clin Gastroenterol. 2006. PMID: 17063114
-
Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic Fatty liver disease.Am J Gastroenterol. 2005 Apr;100(4):850-5. doi: 10.1111/j.1572-0241.2005.41500.x. Am J Gastroenterol. 2005. PMID: 15784031
Cited by
-
Intrahepatic Fat Content and COVID-19 Lockdown in Adults with NAFLD and Metabolic Syndrome.Nutrients. 2022 Aug 24;14(17):3462. doi: 10.3390/nu14173462. Nutrients. 2022. PMID: 36079720 Free PMC article.
-
Regular coffee intake improves liver enzyme levels and liver histology in patients with chronic alcohol consumption, non-alcoholic fatty liver and non-alcoholic steatohepatitis: Report of 259 cases.Hepatol Forum. 2020 Sep 21;1(3):88-96. doi: 10.14744/hf.2020.2020.0026. eCollection 2020 Sep. Hepatol Forum. 2020. PMID: 35949725 Free PMC article.
-
Coffee Consumption and Non-alcoholic Fatty Liver Disease: An Umbrella Review and a Systematic Review and Meta-analysis.Front Pharmacol. 2021 Dec 13;12:786596. doi: 10.3389/fphar.2021.786596. eCollection 2021. Front Pharmacol. 2021. PMID: 34966282 Free PMC article. Review.
-
Caffeine and EGCG Alleviate High-Trans Fatty Acid and High-Carbohydrate Diet-Induced NASH in Mice: Commonality and Specificity.Front Nutr. 2021 Nov 22;8:784354. doi: 10.3389/fnut.2021.784354. eCollection 2021. Front Nutr. 2021. PMID: 34881283 Free PMC article.
-
Narrative review of current and emerging pharmacological therapies for nonalcoholic steatohepatitis.Transl Gastroenterol Hepatol. 2021 Oct 25;6:60. doi: 10.21037/tgh-20-247. eCollection 2021. Transl Gastroenterol Hepatol. 2021. PMID: 34805582 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical